Oklahoma has carried out its first execution of the year on a man convicted of killing two men in a drive-by shooting.
Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...
A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the potential link between ...
Telehealth company Hims & Hers cancels $49 monthly weight-loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Donald Trump says the launch of a new prescription drug website will help Americans without health insurance purchase ...
Amgen is refusing U.S. regulators’ request to withdraw an inflammatory disease drug. Elsewhere, Pfizer battled skepticism on new obesity drug data, and Merck laid out its post-Keytruda future.
Investor's Business Daily on MSN
Pfizer dives; why Lilly's Zepbound still looks like the weight-loss heavyweight
An analyst says Eli Lilly's Zepbound still looks like the heavyweight in weight loss compared to Pfizer's injection.
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Pharmaceutical giant Pfizer (PFE) released its fourth quarter earnings results that topped Wall Street's expectations on its top and bottom lines. The stock is coming under some pressure on Tuesday ...
Evan Seigerman, head of healthcare research at BMO Capital Markets, joins 'Money Movers' to discuss Pfizer and Merck's latest earnings results, market themes, and more. Police return to home of Nancy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results